Airway epithelial cells synthesize proinflammatory molecules such as
IL-8,
GM-CSF,
RANTES, and
ICAM-1, the expression of which is increased in the airways of patients with
asthma. We investigated the regulation of these
NF-kappa B-dependent genes by the novel
protein kinase C (PKC)
isoform PKC delta in 16HBE14o- human airway epithelial cells, focusing on
IL-8 expression. Transient transfection with the constitutively active catalytic subunit of PKC delta (PKC delta-CAT), and treatment with
bryostatin 1, an activator of PKC delta, each increased transcription from the
IL-8 promoter, whereas overexpression of
PKC epsilon had minor effects. Expression of a dominant negative PKC delta mutant (PKC delta-KR) or pretreatment of cells with
rottlerin, a chemical PKC delta inhibitor, attenuated
TNF-alpha- and
phorbol ester-induced transcription from the
IL-8 promoter.
Bryostatin 1 treatment increased
IL-8 protein abundance in primary airway epithelial cells. Selective activation of PKC delta by
bryostatin also activated
NF-kappa B, as evidenced by p65 RelA and p50 NF-kappa B1 binding to
DNA,
NF-kappa B trans-activation, and
I kappa B degradation. The sufficiency of PKC delta to induce
NF-kappa B nuclear translocation and binding to
DNA was confirmed in a 16HBE14o- cell line inducibly expressing PKC delta-CAT under the tet-off system. Deletion of the
NF-kappa B response element severely attenuated PKC delta-induced
IL-8 promoter activity. Finally, PKC delta-CAT induced transcription from the
GM-CSF,
RANTES, and
ICAM-1 promoters. Together these data suggest that PKC delta plays a key role in the regulation of airway epithelial cell
NF-kappa B-dependent gene expression.